Tofacitinib in the treatment of moderate-to-severe rheumatoid arthritis: a cost-effectiveness analysis compared with adalimumab in Taiwan.
- Resource Type
- journal article
- Source
- Journal of Medical Economics; Aug2019, Vol. 22 Issue 8, p777-787, 11p
- Subject
- Language
- ISSN
- 13696998